BSX
Boston Scientific Corporation
Revenue to net incomeLast 12 months
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $21.1B | +15.2% |
| Gross profit | $14.6B | +16.5% |
| Operating income | $3.9B | — |
| Net income | $3.5B | — |
| EPS | $2.36 | — |
| Free cash flow | $3.3B | +26.4% |
Boston Scientific Corporation
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $21.1B | +15.2% |
| Gross profit | $14.6B | +16.5% |
| Operating income | $3.9B | — |
| Net income | $3.5B | — |
| EPS | $2.36 | — |
| Free cash flow | $3.3B | +26.4% |